Top Markets
#1 Black Phoenix Black Phoenix +830.08%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.70%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.09%
#4 Beam Beam +23.20%
#5 SAFEcoin SAFEcoin +20.68%
#6 Magma Finance Magma Finance +17.40%
#7 THORChain THORChain +16.09%
#8 Bless Bless +15.28%
#9 pipedog pipedog +15.15%
#10 PondCoin PondCoin +14.62%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Classifica tra le azioni #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Prezzo delle azioni
$18.55
Capitalizzazione di mercato
$2.40B
Variazione (1 giorno)
0.60%
Variazione (1 anno)
-
Paese
US
Scambia Kailera Therapeutics, Inc. (KLRA)

Categoria

Healthcare
Ricavi di Kailera Therapeutics, Inc. (KLRA)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Kailera Therapeutics, Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Kailera Therapeutics, Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH